Alyssa Miceli, DO
Dermatology · Danbury, CTNPI 1497136758
Payments from drug & device makers
Across 666 payments — averaging $21.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$4K
- Pfizer$1K
- Johnson & Johnson$833
- LEO Pharma Inc.$828
- Incyte Corporation$811
- Sun Pharmaceutical Industries Inc.$800
- plus $5K from 24 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 164 | $4,229 |
| Pfizer | 89 | $1,212 |
| Johnson & Johnson | 51 | $833 |
| LEO Pharma Inc. | 40 | $828 |
| Incyte Corporation | 37 | $811 |
| Sun Pharmaceutical Industries Inc. | 32 | $800 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 29 | $570 |
| Galderma Laboratories, L.p. | 21 | $567 |
| UCB, Inc. | 21 | $546 |
| Lilly USA, LLC | 29 | $541 |
| Regeneron Healthcare Solutions, Inc. | 17 | $527 |
| Amgen | 24 | $446 |
| Sanofi | 16 | $383 |
| Novartis | 24 | $377 |
| Arcutis Biotherapeutics, Inc. | 16 | $354 |
| Dermavant Sciences, Inc. | 20 | $228 |
| Journey Medical Corporation | 9 | $195 |
| EPI Health, LLC | 4 | $138 |
| E.r. Squibb & Sons, L.L.C. | 6 | $127 |
| Bristol Myers Squibb | 1 | $81 |
| Verrica Pharmaceuticals Inc. | 3 | $58 |
| Boehringer Ingelheim | 3 | $54 |
| Hydrofera LLC | 2 | $51 |
| Organon | 2 | $23 |
| Biofrontera Inc. | 1 | $22 |
| Almirall LLC | 1 | $19 |
| VYNE Pharmaceuticals Inc. | 1 | $18 |
| Fresenius Kabi USA, LLC | 1 | $17 |
| Sandoz | 1 | $17 |
| Mayne Pharma Commercial LLC | 1 | $16 |
How this compares
$14,088 in reported general payments places this provider in the 80th percentile of 222 dermatology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other dermatology in Danbury
- Graeme LipperDanbury$216K
- Mona GoharaDanbury$209K
- Jonathan ZirnDanbury$15K
- Brett KingFairfield$6.1M
- Michael PayetteCromwell$3.4M
- Bruce StroberCromwell$3.3M
- Lisa DonofrioNew Haven$2.3M
- Mona ShahriariCromwell$2.3M
- Jeremy MossMadison$2.2M
- Brittany CraiglowFairfield$1.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.